Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹17Cr
Hospitals/Medical Services
Rev Gr TTM
Revenue Growth TTM
-98.60%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

FAMILYCARE
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 61.1 | 6.1 | 9.5 | 3.5 | -69.0 | -66.7 | -68.8 | -99.7 | -99.5 | -99.5 | -98.2 | 100.0 |
| 11 | 10 | 10 | 10 | 3 | 4 | -27 | 2 | 1 | 0 | 4 | 1 |
Operating Profit Operating ProfitCr |
| 16.1 | 19.0 | 16.2 | 13.1 | 22.6 | 6.0 | 798.2 | -5,833.3 | -5,200.0 | -1,950.0 | -6,271.4 | -1,133.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 1 | 2 | 0 | -74 | 0 | 2 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 2 | 2 | 2 | 3 | 0 | -43 | -2 | 1 | -1 | -5 | -1 |
| 1 | 1 | 1 | 0 | -6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 21.5 | 3.1 | -13.7 | -5.9 | 560.0 | -82.8 | -3,534.1 | -287.5 | -88.5 | -404.4 | 89.3 | 54.3 |
| 9.5 | 11.2 | 10.1 | 9.8 | 202.4 | 5.8 | -1,115.2 | -7,000.0 | 4,950.0 | -3,500.0 | -6,585.7 | -1,600.0 |
| 0.2 | 0.3 | 0.3 | 0.2 | 1.6 | 0.0 | -8.0 | -0.4 | 0.2 | -0.1 | -0.8 | -0.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 408.5 | 1,470.7 | 68.0 | 188.6 | 173.5 | -6.7 | 166.9 | 19.0 | -0.1 | -4.8 | -80.2 | -97.8 |
| 0 | 1 | 2 | 4 | 13 | 11 | 28 | 33 | 34 | 33 | -21 | 7 |
Operating Profit Operating ProfitCr |
| -256.8 | 19.5 | 14.8 | 25.9 | 10.2 | 16.1 | 22.2 | 20.5 | 19.8 | 16.9 | 359.4 | -3,823.5 |
Other Income Other IncomeCr | -25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | -71 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| -25 | 0 | 0 | 1 | 0 | 0 | 6 | 7 | 7 | 8 | -44 | -6 |
| 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | -4 | 0 | 0 |
|
| -7,297.9 | 100.1 | 681.0 | 444.2 | -97.8 | 49.1 | 14,214.8 | 27.6 | 1.1 | 138.7 | -451.8 | 88.0 |
| -36,440.5 | 1.9 | 8.8 | 16.5 | 0.1 | 0.2 | 11.5 | 12.4 | 12.5 | 31.4 | -558.5 | -3,105.9 |
| -17.6 | 0.0 | 0.1 | 0.3 | 0.0 | 0.0 | 1.2 | 1.5 | 0.2 | 2.3 | -8.2 | -1.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 54 | 54 | 54 | 54 |
| -28 | -28 | -28 | -27 | -27 | -27 | -23 | -18 | -8 | 4 | -41 | -46 |
Current Liabilities Current LiabilitiesCr | 1 | 1 | 1 | 5 | 9 | 5 | 5 | 20 | 22 | 10 | 32 | 36 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 7 | 6 | 6 | 7 | 2 | 0 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 3 | 3 | 2 | 0 | 3 | 6 | 11 | 32 | 59 | 55 | 41 | 41 |
Non Current Assets Non Current AssetsCr | 2 | 2 | 3 | 9 | 10 | 11 | 9 | 8 | 16 | 14 | 5 | 4 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 0 | 3 | 1 | -1 | 4 | 2 | -5 | 0 | -17 |
Investing Cash Flow Investing Cash FlowCr | -2 | 0 | -1 | -5 | -2 | -2 | 0 | 0 | -2 | 0 | 1 |
Financing Cash Flow Financing Cash FlowCr | 5 | 0 | 1 | 0 | 1 | 5 | -5 | -2 | 26 | -1 | -1 |
|
Free Cash Flow Free Cash FlowCr | -2 | 0 | -1 | -2 | 0 | -4 | 4 | 1 | -7 | -1 | -17 |
| 0.3 | 1,698.0 | 291.0 | 354.4 | 6,348.3 | -4,532.5 | 95.8 | 32.4 | -100.0 | -3.0 | 39.2 |
CFO To EBITDA CFO To EBITDA% | 38.6 | 163.9 | 172.7 | 226.2 | 83.4 | -60.6 | 49.8 | 19.6 | -63.1 | -5.5 | -61.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 26 | 53 | 59 | 0 | 35 | 50 | 63 | 61 | 38 | 19 |
Price To Earnings Price To Earnings | 0.0 | 823.0 | 330.0 | 68.5 | 0.0 | 1,100.0 | 12.2 | 12.1 | 11.6 | 3.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 24.7 | 29.4 | 11.4 | 0.0 | 2.7 | 1.4 | 1.5 | 1.4 | 0.9 | 2.5 |
Price To Book Price To Book | 0.0 | 6.7 | 12.9 | 12.0 | 0.0 | 7.0 | 5.5 | 4.4 | 1.3 | 0.7 | 1.4 |
| 12.4 | 116.7 | 190.9 | 44.2 | -0.1 | 20.3 | 7.0 | 7.8 | 5.5 | 3.5 | 0.8 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 97.8 | 95.4 | 94.6 | 89.5 | 65.2 | 64.9 | 64.5 | 566.7 |
| -256.8 | 19.5 | 14.8 | 25.9 | 10.2 | 16.1 | 22.2 | 20.5 | 19.8 | 16.9 | 359.4 |
| -36,440.5 | 1.9 | 8.8 | 16.5 | 0.1 | 0.2 | 11.5 | 12.4 | 12.5 | 31.4 | -558.5 |
| -554.4 | 0.6 | 4.9 | 23.0 | 10.6 | 6.0 | 44.2 | 40.5 | 15.8 | 13.7 | -262.2 |
| -634.1 | 0.5 | 3.9 | 17.3 | 0.4 | 0.6 | 44.9 | 36.5 | 11.5 | 21.5 | -328.0 |
| -549.6 | 0.4 | 2.9 | 8.7 | 0.1 | 0.2 | 20.0 | 13.1 | 7.0 | 17.9 | -95.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Family Care Hospitals Limited (FCHL) is an emerging multi-specialty healthcare provider based in the Mumbai Metropolitan Region (MMR), operating under the brands *Family Care Hospitals* and *Scandent Imaging*. The company integrates **physical infrastructure with digital innovation** to deliver accessible, affordable, and comprehensive healthcare services across hospitals, diagnostics, pharmacy, and digital/home-based care.
FCHL’s operations are structured into four core verticals:
- **Hospitals**: 100-bed NABH-accredited tertiary care facility in Mira Road, Thane
- **Imaging**: 9 diagnostic centers under the brand ‘Scandent’ offering dental and ENT imaging via CBCT technology
- **Pharmacy**: In-house 24x7 pharmacy integrated with digital platforms
- **New Generation Healthcare & Support Services**: Teleconsultations, e-pharmacy, e-pathology, home care, and digital health packages
The company serves both **B2C and B2B markets**, with a strategic focus on suburban and underpenetrated areas of Mumbai, Thane, and Western Maharashtra.
---
### **Recent Developments (Jun 2025)**
- **Convertible Warrants Issuance**: To ensure operational continuity and avoid litigation, FCHL is issuing **convertible warrants** to settle outstanding vendor liabilities, including those to the promoter group. This move signals financial restructuring efforts amid funding needs.
- **Digital-First Platform Expansion**: FCHL is advancing its **digital healthcare platform**, enabling:
- Electronic Health Records (EHR)
- Online consultations (audio/video)
- Digital diagnostics and medicine delivery
- Personalized health monitoring for domestic and international users
- **Hybrid Care Model**: Establishing local and international entities to support **physical diagnostics and care coordination**, creating a seamless **omnichannel patient experience**.
- **Funding Requirement**: Anticipates substantial investment in:
- Product development
- Marketing & sales
- Data/AI infrastructure
- Expansion of physical facilities
---
### **Strategic Growth Drivers**
#### **1. Geographical & Physical Expansion**
- **Mira Road Hospital Expansion**: Ongoing acquisition of land for hospital expansion as part of the Mira Road strategic hub.
- **Tier 3 City Focus**: Targeting **rural and semi-urban areas** in Western Maharashtra, leveraging a **lease rental business model** due to existing infrastructure and medical talent availability.
- **Portfolio Diversification**: Expanding surgical volumes at existing hospitals and planning **new facility openings** in high-demand areas.
#### **2. Digital Transformation & E-Commerce Models**
- **Family Care Mobile App & Website**: Offers end-to-end digital services including:
- Doctor appointments
- e-surgery consultations
- Lab test bookings
- Medicine ordering and home delivery
- Patient record storage
- **Bundled Health Packages**:
- Sold via **Dealmoney Distribution and E-Marketing Pvt Ltd (DDEPL)**, a related party.
- Packages valid for 1–2 years; include unlimited free OPD, audio/video consultations, medicine discounts, reduced test fees, and limited free IPD services (surgery, hospitalization).
- **Health Coupons / Membership Model (“Family Care 911 Health Package”)**:
- Drives customer acquisition and retention.
- Has significantly boosted revenue and patient inflow since FY23.
#### **3. Strategic Partnerships & Marketing**
- **MOU with DDEPL**:
- Agreement for **100,000 patient leads** over 12 months at ₹400/lead (up to ₹4 crore).
- Includes social media content, SEO, app optimization, and lead generation.
- **Multi-Channel Marketing**:
- Combines traditional (print, radio) and digital (social media, SEM) methods.
- Health camps and corporate engagement to deepen community outreach.
#### **4. Operational Excellence & Financial Optimization**
- **Cost Optimization Initiatives**:
- Rationalizing drug and consumable costs
- Optimizing CapEx and indirect spending
- Turnaround of underperforming centers
- **EBITDA & ROCE Improvement**: Focused on enhancing profitability and capital efficiency in the Healthcare Services segment.
- **Revenue Stream Diversification**:
- Diagnostic services benefiting from **home collection, online booking, and fast digital reporting**.
- Pharmacy revenue linked primarily to hospital footfall (secondary growth pillar).
---
### **Key Operational Metrics & Historical Context**
| Metric | Detail |
|-------|--------|
| **Hospital Facility** | 100-bed, NABH-accredited hospital in Mira Road, Thane<br>- 21,000–25,000 sq ft<br>- Services: Emergency, ICUs, Cath Lab, Oncology, Cardiology, Neurology, Women & Child Care, etc. |
| **Medical Team** | ~135 staff + 60–70+ affiliated consultants across specialties |
| **Patient Volume (Historic)** | Over **40,000 patients treated** cumulatively as of Apr 2022<br>- Surgeon >4,000 procedures performed |
| **Bed Occupancy (as of Oct 2022)** | Declined to **49.7% (2022)** from 75.4% (2020)<br>- ARPOB increased to ₹11,092 in 2022 from ₹5,135 in 2020 |
| **Outpatient Growth** | Tripled from 3,417 (2020) to 11,214 (2022) |
| **Imaging Division** | 9 centers under ‘Scandent’ – **largest independent dental/ENT imaging chain in Mumbai**<br>- Utilizes **CBCT technology** for craniofacial diagnostics |
| **Revenue Contribution (FY22)** | Hospital division contributed **94.61%** of total revenue |
---
### **Challenges & Risks**
- **Single Hospital Dependency**: Heavy reliance on one hospital limits scalability unless new acquisitions or greenfield projects are executed.
- **Physician Retention Risk**: Dependent on attracting high-net-worth physicians with strong referral networks; vulnerable to market competition and payment delays.
- **Funding Needs**: Ambitious digital and physical expansion requires significant capital, which may strain balance sheet without external funding or equity conversion.
- **Bed Occupancy Pressure**: Despite growth in OPD, **inpatient utilization has declined**, suggesting need for improved marketing or specialized service pull.